These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34757587)

  • 21. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
    Wolf M; Koch TA; Bregman DB
    J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of fibroblast growth factor 23 in regulation of phosphate balance.
    Wilson R; Mukherjee-Roy N; Gattineni J
    Pediatr Nephrol; 2024 Dec; 39(12):3439-3451. PubMed ID: 38874635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity.
    Clinkenbeard E
    Calcif Tissue Int; 2023 Jul; 113(1):4-20. PubMed ID: 37306735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.
    Hori M; Shimizu Y; Fukumoto S
    Endocrinology; 2011 Jan; 152(1):4-10. PubMed ID: 21084445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.
    Alon US
    Eur J Pediatr; 2011 May; 170(5):545-54. PubMed ID: 21193927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation regulates fibroblast growth factor 23 production.
    Francis C; David V
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):325-32. PubMed ID: 27191351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bone is the major source of high circulating intact fibroblast growth factor-23 in acute murine polymicrobial sepsis induced by cecum ligation puncture.
    Bayer J; Vaghela R; Drechsler S; Osuchowski MF; Erben RG; Andrukhova O
    PLoS One; 2021; 16(5):e0251317. PubMed ID: 33989306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
    Daryadel A; Bettoni C; Haider T; Imenez Silva PH; Schnitzbauer U; Pastor-Arroyo EM; Wenger RH; Gassmann M; Wagner CA
    Pflugers Arch; 2018 Oct; 470(10):1569-1582. PubMed ID: 29961920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
    Ohnishi M; Razzaque MS
    Contrib Nephrol; 2013; 180():1-13. PubMed ID: 23652546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphate-Sensing.
    Takashi Y; Fukumoto S
    Adv Exp Med Biol; 2022; 1362():27-35. PubMed ID: 35288870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease.
    Kurpas A; Supeł K; Idzikowska K; Zielińska M
    Dis Markers; 2021; 2021():8821292. PubMed ID: 34055103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling.
    Egli-Spichtig D; Zhang MYH; Li A; Pastor Arroyo EM; Hernando N; Wagner CA; Chang W; Perwad F
    Sci Rep; 2021 Mar; 11(1):6175. PubMed ID: 33731726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.
    Liu S; Guo R; Simpson LG; Xiao ZS; Burnham CE; Quarles LD
    J Biol Chem; 2003 Sep; 278(39):37419-26. PubMed ID: 12874285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.
    Courbon G; Martinez-Calle M; David V
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):359-366. PubMed ID: 32452919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.
    Czaya B; Heitman K; Campos I; Yanucil C; Kentrup D; Westbrook D; Gutierrez O; Babitt JL; Jung G; Salusky IB; Hanudel M; Faul C
    Elife; 2022 Mar; 11():. PubMed ID: 35302487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney.
    Simic P; Kim W; Zhou W; Pierce KA; Chang W; Sykes DB; Aziz NB; Elmariah S; Ngo D; Pajevic PD; Govea N; Kestenbaum BR; de Boer IH; Cheng Z; Christov M; Chun J; Leaf DE; Waikar SS; Tager AM; Gerszten RE; Thadhani RI; Clish CB; Jüppner H; Wein MN; Rhee EP
    J Clin Invest; 2020 Mar; 130(3):1513-1526. PubMed ID: 32065590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
    van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
    Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.